Neosoma Incorporates Wholly-Owned Swiss Subsidiary
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the
Neosoma, Inc., developer of a software medical device platform to help advance brain cancer care and clinical trials, announced the incorporation of a wholly-owned subsidiary
Memento
By 2026, over 80% of enterprises are expected to deploy generative AI (GenAI) apps or use GenAI APIs, transforming industries like healthcare, finance, and public services. 🚀 #AI #GenerativeAI #FutureTech
Source: Gartner
Marc Andreessen's latest prediction is insane:
"AI will make everything so cheap, it'll break the economy."
Those who understand this will build generational wealth.
Time is running out. Here's how to prepare yourself: